Previous Page  5 / 20 Next Page
Information
Show Menu
Previous Page 5 / 20 Next Page
Page Background

allied

academies

Virology Research Journal

Volume 1 Issue 4

Vaccines World 2017

Notes:

Page 37

November 09-10, 2017 Vienna, Austria

21

st

World Congress and Exhibition on

VACCINES, VACCINATION & IMMUNIZATION

Immunological evaluation of HCV core and

its alternative reading frame protein vaccine

prototypes

Irina Sominskaya, Juris Jansons, Anastasija Dovbenko, Ivars Petrovskis

and

Dace Skrastina

Latvian Biomedical Research and Study Center, Latvia

H

epatitis C remains a serious healthcare problem and there is

no prophylactic or therapeutic vaccine currently available,

although many candidates are in clinical trials. One of the

attractive targets is the nucleocapsid protein (core). HCV core (aa

1-191) is highly conserved among HCV genotypes. It binds and

packages viral genomic RNA and regulates its translation. The 5'

terminus of HCV genome also encodes core+1/ARF protein. This

protein possibly participates in HCV morphology or replication,

it can be important in gene regulation and it can affect immune

response mechanisms. A set of plasmids for eukaryotic and

prokaryotic expression carrying different in length variants of the

5' terminus of HCV genome were constructed. Obtained DNA

and proteins were purified and used in immunization of BALB/c

mice in different schemes of immunization by protein and naked

DNA (

in vivo

electroporation). Specific immune response was

determined and immunization with HCV core aa 1-159 and full

length ARFP proteins expressed in E. coli induced the specific

immune response. The antibody titers against HCV core reached

104 and maximum antibody titers against ARFP reached 103.

Immunization with HCV core and ARFP genes also induced

the specific immune response. Both natural and mutated HCV

core genes with prohibited frame-shift provide the same levels

of specific cellular responses. Thus, a higher expression of HCV

core from the mutated or optimized genes compared to the wild

type sequence could not provide for its better immunogenicity.

Efficacy of ARFP expression by the natural ribosome frameshift

mechanism was low and obviously insufficient to induce a

specific immune response. Thus, anti-ARFP immune response is

not competing with that against HCV core, and cannot explain

low immunogenicity of core in DNA-immunization performed

with the virus-derived genes. The immunization by DNA-prime

and protein-boost seems to combine the advantages of both

approaches and improve the immune response.

Recent Publications

• Sominskaya I, Jansons J, Dovbenko A, et al (2015)

Comparative immunogenicity in rabbits of the polypeptides

encoded by the 5' terminus of hepatitis C virus RNA. J

Immunol Res.

http://dx.doi.org/10.1155/2015/762426.

• Dishlers A, Skrastina D, Renhofa R, et al (2015)The hepatitis

B virus core variants that expose foreign C-terminal

insertions on the outer surface of virus-like particles. Mol

Biotechnol. 57(11-12):1038-49.

• Ivanov A V, Smirnova O A, Petrushanko I Y, et al (2015)

HCV core protein uses multiple mechanisms to induce

oxidative stress in human hepatoma Huh7 cells. Viruses

7(6):2745-70.

• Sominskaya I, Skrastina D, Petrovskis I, et al (2013) A VLP

library of C-terminally truncated hepatitis B core proteins:

correlation of RNA encapsidation with a Th1/Th2 switch in

the immune responses of mice. PLoS One. 8(9):e75938.

• Skrastina D, Petrovskis I, Petraityte R, et al (2013) Chimeric

derivatives of hepatitis B virus core particles carrying major

epitopes of the rubella virus E1 glycoprotein. Clin Vaccine

Immunol. 20(11):1719-28.

Biography

Irina Sominskaya has completed her Doctor of Biology Degree from Latvian

University, Riga, Latvia in 1992. She is the Head of Viral hepatitis group of

Latvian Biomedical Research and Study Center, Riga, Latvia. Using a

multidisciplinary approach, including molecular biology, cell biology, and

immunology technologies, the objective of group research is to gain a deeper

understanding of virus-host interactions at a fundamental level. She has 25

publications and was a project Leader of several Latvian and international

projects. She was supervisor of four doctoral degree students.

irina@biomed.lu.lv

Irina Sominskaya et al., Virol Res J 2017, 1:4